European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

被引:54
作者
Panzuto, Francesco [1 ,11 ]
Ramage, John [2 ,3 ]
Pritchard, D. Mark [4 ]
van Velthuysen, Marie-Louise F. [5 ]
Schrader, Joerg [6 ]
Begum, Nehara [7 ]
Sundin, Anders [8 ]
Falconi, Massimo [9 ]
O'Toole, Dermot [10 ]
机构
[1] Sapienza Univ Rome, St Andrea Univ Hosp, ENETS Ctr Excellence, Dept Med Surg Sci & Translat Med,Digest Dis Unit, Rome, Italy
[2] Hampshire Hosp, Dept Gastroenterol, Kings Hlth Partners London, London, England
[3] ENETS Ctr, Kings Hlth Partners London, London, England
[4] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, England
[5] Erasmus MC, Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands
[6] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany
[7] Ruhr Univ Bochum, Univ Hosp, Dept Gen Visceral Thorac & Endocrine Surg, Johannes Wesling Klinikum Minden, Bochum, Germany
[8] Uppsala Univ, Dept Surg Sci Radiol & Mol Imaging, Uppsala, Sweden
[9] IRCCS San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, Pancreat Surg Unit, Milan, Italy
[10] St Vincents Univ Hosp, Natl Ctr Neuroendocrine Tumours, ENETS Ctr Excellence, Dublin, Ireland
[11] Sapienza Univ Rome, ENETS Ctr Excellence, Dept Med Surg Sci & Translat Med, Digest Dis Unit,St Andrea Univ Hosp, Via Grottarossa 1035, I-00189 Rome, Italy
关键词
duodenal neuroendocrine tumours; gastric carcinoids; guidelines; management; prognosis; AMPULLARY CARCINOID-TUMORS; ZOLLINGER-ELLISON SYNDROME; ENDOSCOPIC SURVEILLANCE; CONSENSUS GUIDELINES; PROGNOSTIC-FACTORS; MANAGEMENT; DIAGNOSIS; SURVIVAL; FEATURES; DISEASE;
D O I
10.1111/jne.13306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.
引用
收藏
页数:14
相关论文
共 65 条
  • [1] ZOLLINGER-ELLISON SYNDROME CAN BE THE INITIAL ENDOCRINE MANIFESTATION IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA-TYPE-I
    BENYA, RV
    METZ, DC
    VENZON, DJ
    FISHBEYN, VA
    STRADER, DB
    ORBUCH, M
    JENSEN, RT
    [J]. AMERICAN JOURNAL OF MEDICINE, 1994, 97 (05) : 436 - 444
  • [2] ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors
    Borbath, Ivan
    Pape, Ulrich-Frank
    Deprez, Pierre H.
    Bartsch, Detlef Klaus
    Caplin, Martyn
    Falconi, Massimo
    Garcia-Carbonero, Rocio
    Grozinsky-Glasberg, Simona
    Jensen, Robert T.
    Arnold, Rudolf
    Ruszniewski, Philippe
    Toumpanakis, C.
    Valle, Juan W.
    Toole, Dermot O.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (03)
  • [3] Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
    Boyce, Malcolm
    Moore, Andrew R.
    Sagatun, Liv
    Parsons, Bryony N.
    Varro, Andrea
    Campbell, Fiona
    Fossmark, Reidar
    Waldum, Helge L.
    Pritchard, D. Mark
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (03) : 466 - 475
  • [4] Selective Resection of Type 1 Gastric Neuroendocrine Neoplasms and the Risk of Progression in an Endoscopic Surveillance Programme
    Chin, Jun Liong
    O'Connell, Jim
    Muldoon, Cian
    Swan, Niall
    Reynolds, John Vincent
    Ravi, Narayanasamy
    Geoghegan, Justin
    Conlon, Kevin C.
    O'Shea, Donal
    O'Toole, Dermot
    [J]. DIGESTIVE SURGERY, 2021, 38 (01) : 38 - 45
  • [5] Chin JL, 2017, CLIN ENDOSC, V50, P520, DOI 10.5946/ce.2017.181
  • [6] Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment A Digestive Endoscopy Society of Tawian (DEST)
    Chung, Chen-Shuan
    Tsai, Cho-Lun
    Chu, Yin-Yi
    Chen, Kuan-Chih
    Lin, Jung-Chun
    Chen, Bao-Chung
    Sun, Wei-Chih
    Yen, Hsu-Heng
    Chen, Chiung-Yu
    Wu, I-Chen
    Kuo, Chao-Hung
    Shih, Hisang-Yao
    Bair, Ming-Jong
    Wang, Jack P.
    Hu, Wen-Hao
    Yang, Chang-Shyue
    Han, Ming-Lun
    Cheng, Tsu-Yao
    Tseng, Chao-Ming
    Tsai, Ming-Chang
    Hu, Ming-Luen
    Wang, Hsiu-Po
    [J]. MEDICINE, 2018, 97 (38)
  • [7] Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
    Dasari, Arvind
    Shen, Chan
    Halperin, Daniel
    Zhao, Bo
    Zhou, Shouhao
    Xu, Ying
    Shih, Tina
    Yao, James C.
    [J]. JAMA ONCOLOGY, 2017, 3 (10) : 1335 - 1342
  • [8] Treatment outcomes of advanced digestive well-differentiated grade 3 NETs
    de Mestier, Louis
    Lamarca, Angela
    Hernando, Jorge
    Zandee, Wouter
    Alonso-Gordoa, Teresa
    Perrier, Marine
    Walenkamp, Annemiek M. E.
    Chakrabarty, Bipasha
    Landolfi, Stefania
    Van Velthuysen, Marie-Louise F.
    Kats-Ugurlu, Gursah
    Caminoa, Alejandra
    Ronot, Maxime
    Manoharan, Prakash
    Garcia-Alvarez, Alejandro
    Brabander, Tessa
    Garcia Gomez-Muriel, Maria Isabel
    Cadiot, Guillaume
    Couvelard, Anne
    Capdevila, Jaume
    Pavel, Marianne E.
    Cros, Jerome
    [J]. ENDOCRINE-RELATED CANCER, 2021, 28 (08) : 549 - 561
  • [9] ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
    Delle Fave, Gianfranco
    Kwekkeboom, Dik J.
    Van Cutsem, Erik
    Rindi, Guido
    Kos-Kudla, Beata
    Knigge, Ulrich
    Sasano, Hironobu
    Tomassetti, Paola
    Salazar, Ramon
    Ruszniewski, Philippe
    [J]. NEUROENDOCRINOLOGY, 2012, 95 (02) : 74 - 87
  • [10] Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy
    Dogeas, Epameinondas
    Cameron, John L.
    Wolfgang, Cristopher L.
    Hirose, Kenzo
    Hruban, Ralph H.
    Makary, Martin A.
    Pawlik, Timothy A.
    Choti, Michael A.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (08) : 1262 - 1269